Predicting Complications of Hepatolithiasis After Hepatectomy
Launched by FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY · Sep 23, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Along with the change of lifestyle and dietary habits, many people are diagnosed with hepatolithiasis that is especially prevalent in Asia. Liver resection remains the favorable curative therapy for hepatolithiasis with a relatively low recurrence rate. Although there have been great improvements in surgical techniques and perioperative management, postoperative complications remain commonplace and seriously threat the recovery of patients undergoing hepatectomy. Therefore, it is important to identify risk factors of complications to improve the overall prognosis of patients. We want to col...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • pathologically diagnosed hepatolithiasis
- • without malignancies
- • receiving liver resection
- • Eastern Cooperative Oncology Group performance status (ECOG-PS) 0-2
- • Child-Pugh score of ≤7
- • complete clinical and follow-up information
- • age between 18-80 years old
- Exclusion Criteria:
- • with malignancies
- • receiving other treatments
- • Eastern Cooperative Oncology Group performance status (ECOG-PS) \>2
- • Child-Pugh score of \>7
- • incomplete clinical data
- • lost to follow up
- • age \<18 years old or \>80 years old
About First Affiliated Hospital Of Wenzhou Medical University
The First Affiliated Hospital of Wenzhou Medical University is a leading clinical institution dedicated to advancing healthcare through innovative research and comprehensive patient care. As a prominent teaching hospital, it integrates clinical practice with education and research, fostering a collaborative environment for healthcare professionals and researchers. The hospital is committed to conducting high-quality clinical trials that adhere to rigorous ethical standards, aiming to enhance medical knowledge and improve treatment outcomes. With state-of-the-art facilities and a multidisciplinary team of experts, the First Affiliated Hospital plays a pivotal role in the development of new therapies and the translation of scientific discoveries into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wenzhou, Zhejiang, China
Patients applied
Trial Officials
Gang Chen, MD,PhD
Principal Investigator
First Affiliated Hospital of Wenzhou Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials